Cardinal Partners

Seed to Growth venture capital firm

Cardinal Partners is a Seed to Growth venture capital firm that invests in Healthcare, Life Sciences and Healthcare IT. DryPowder has no SEC Form D on file for Cardinal Partners as of June 3, 2026.

Updated · Sources: fund website

Stages
Seed–Growth

Overview

Cardinal Partners at a glance

Stage
Seed, Early-Stage, Growth
Sectors
Healthcare, Life Sciences, Healthcare IT, Biopharmaceuticals
Cold inbound
Accepted

Investment thesis

Since 1996, Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies as early/growth stage partners, believing waves of healthcare reform create opportunities to deliver more care to more people for less money.

Stated on cardinalpartners.comWEBSITE

What sets Cardinal Partners apart

  • 25+ year track record (1996-present)
  • Positioned as founding/first institutional investor in portfolio companies
  • 25+ IPO participations with $15B+ cumulative portfolio market valuation
  • Deep networks in academic, clinical, and industry communities

What the portfolio shows

Get Starter to see what the portfolio reveals

Portfolio 11

Backed: QPID Health, Sirtris Pharmaceuticals, Ivenix + 8 more

Get Starter for the full portfolio

Partners

Partners at Cardinal Partners

Team data is not yet available for Cardinal Partners. Visit the website

Similar funds

Funds like Cardinal Partners

FAQ

Questions about Cardinal Partners

What does Cardinal Partners invest in?

Cardinal Partners is a Seed, Early-Stage, Growth stage Healthcare, Life Sciences, Healthcare IT, Biopharmaceuticals investor, primarily investing in US. Their thesis: Since 1996, Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies as early/growth stage partners, believing waves of healthcare reform create opportunities to deliver more care to more people for less money.

What makes Cardinal Partners different from other funds?

Cardinal Partners stands out on 4 points: 25+ year track record (1996-present); Positioned as founding/first institutional investor in portfolio companies; 25+ IPO participations with $15B+ cumulative portfolio market valuation; Deep networks in academic, clinical, and industry communities.

What other funds are similar to Cardinal Partners?

Funds with an overlapping stage and sector focus include Caffeinated Capital, Aspira Capital Management, Initialized Capital.

How do I reach Cardinal Partners?

Cardinal Partners accepts cold inbound, so a warm introduction is not required.